Old Web
English
Sign In
Acemap
>
authorDetail
>
Charlie Iaconangelo
Charlie Iaconangelo
Medicine
Internal medicine
Patient-reported outcome
Fabry disease
Clinical trial
5
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Fabry disease patient-reported outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry disease
2021
Molecular genetics and metabolism reports
Alaa Hamed
Pronabesh DasMahapatra
Nicole Lyn
Chad J. Gwaltney
Charlie Iaconangelo
Daniel Serrano
Vijay Modur
Juan Politei
Show All
Source
Cite
Save
Citations (0)
Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial.
2021
Journal of Pain Research
Richard B. Lipton
Sagar Munjal
David W. Dodick
Stewart J. Tepper
Daniel Serrano
Charlie Iaconangelo
Show All
Source
Cite
Save
Citations (1)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura.
2021
Journal of Pain Research
Richard B. Lipton
Sagar Munjal
Stewart J. Tepper
Charlie Iaconangelo
Daniel Serrano
Show All
Source
Cite
Save
Citations (0)
Measurement properties of the Fabry Disease Patient Reported Outcome (FD-PRO), a new instrument to measure symptoms in Fabry disease
2019
Molecular Genetics and Metabolism
Alaa Hamed
Pronabesh DasMahapatra
Charlie Iaconangelo
Daniel Serrano
Chad Gwaltney
Show All
Source
Cite
Save
Citations (1)
Measuring Patient Reported Outcomes in Multiple Myeloma: Are Legacy Instruments Fit for Purpose
2018
Blood
Katharine S. Gries
John Fastenau
Charlie Iaconangelo
Daniel Serrano
Show All
Source
Cite
Save
Citations (0)
1